文献速递肝病

非酒精性脂肪性肝病的流行病学变化、全球趋势及对结局的影响

Changing epidemiology, global trends and implications for outcomes of NAFLD.
PubMed 文献 · J Hepatol · 2023-05-09

非酒精性脂肪性肝病(NAFLD)已成为全球最常见的肝脏疾病,估计影响全球38%的人口。本文为叙述性综述,讨论NAFLD和非酒精性脂肪性肝炎(NASH)在区域和全球视角及特殊人群中流行病学的最新变化,以及这些变化对肝脏和肝外事件的潜在影响。

要点

  • NAFLD估计影响全球38%的人口,已成为全球最常见的肝脏疾病。
  • NAFLD发病年龄趋于年轻化,使患者有更长时间发展为严重并发症。
  • NAFLD和NASH患病率存在巨大地理差异,部分与社会经济环境和遗传易感性相关。

核心结论

  • NAFLD已成为全球最常见的肝脏疾病,估计影响全球38%的人口,且全球受累比例预计将进一步增加。
  • 仅少数NAFLD患者会进展为肝硬化或肝细胞癌,但庞大人口基数下存在严重结局风险的患者总数正在增加。
  • NAFLD发病年龄日益年轻化,意味着患者有更多时间发展为严重并发症。

研究设计与样本

  • 叙述性综述,讨论NAFLD和NASH流行病学在区域和全球视角及特殊人群中的最新变化。

主要发现

  • NAFLD估计影响全球38%的人口。
  • NAFLD和NASH患病率存在巨大地理差异,部分与社会经济环境和遗传易感性相关。
  • 随着饮食构成和城市化变化,以及全球人口中肥胖和2型糖尿病的增长(尤其在发展中国家),全球NAFLD受累比例预计将进一步增加。
  • NAFLD发病年龄日益年轻化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver disease globally and is currently estimated to affect 38% of the global population. Only a minority of patients with NAFLD will progress to cirrhosis or hepatocellular carcinoma, but from this vast population the total number of patients who are at risk of such severe outcomes is increasing. Worryingly, individuals are increasingly being affected by NAFLD at an earlier age, meaning there is more time for them to develop severe complications. With considerable changes in dietary composition and urbanisation, alongside the growth in obesity and type 2 diabetes in the global population, in particular in developing countries, the global proportion of persons affected by NAFLD is projected to increase further. Yet, there are large geographical discrepancies in the prevalence rates of NAFLD and its inflammatory component non-alcoholic steatohepatitis (NASH). Such differences are partly related to differing socio-economic milieus, but also to genetic predisposition. In this narrative review, we discuss recent changes in the epidemiology of NAFLD and NASH from regional and global perspectives, as well as in special populations. We also discuss the potential consequences of these changes on hepatic and extrahepatic events.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Wong VW, Ekstedt M, Wong GL, et al. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023. PMID: 37169151. doi:10.1016/j.jhep.2023.04.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。